Logo_BioActor

 

BioActor

Introduction

BioActor B.V., headquartered at the Maastricht Health Campus, is a product development company that supplies proprietary biologically active ingredients to the nutrition & healthcare industry. The company focuses on the development of innovative health ingredients that address the metabolic syndrome and ageing related chronic health conditions. The goal is to provide the nutrition & healthcare industry with science-based innovations that confer long-term health benefits to the consumer. The Company is managed by Hans van der Saag, CEO.

Contribution to the FibeBiotics project

For the FibeBiotics EU project, BioActor provides a specific ingredient to the project: NAXUS, an arabinoxylan concentrate with clinically proven effects on glycemic control in Type II diabetes patients. In addition, in vitro and animal data show strong prebiotic properties and protective effects against weight gain under conditions of high caloric intake. Moreover, animal studies show immune-protective effects of NAXUS. BioActor actively participates in pilot product manufacturing, the development of new processing technologies, as well as market research and advice regarding product exploitation and regulatory status.

Website

Website: www.bio-actor.com

Contact

Hans van der Saag

CEO at BioActor

Phone: +31 433885899

Cell: + 31 611734108

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.">This email address is being protected from spambots. You need JavaScript enabled to view it." target="_blank">This email address is being protected from spambots. You need JavaScript enabled to view it.